HOXA9 overexpression was also identified in many different leukemia subtypes, including onco-fusion proteins, NPM1c+, etc.; experimental validation of the target binding site and cellular function is interesting for understanding HOXA9’s role in other HOXA9-driven leukemia cells. The gene discussed is HOXA9; the disease is leukemia.